Middle East & Africa Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The embolization devices market in the Middle East and Africa is projected to grow significantly, reaching an estimated US$ 162.93 million by 2031, up from US$ 93.26 million in 2024. This growth represents a compound annual growth rate (CAGR) of 8.3% from 2025 to 2031.

Executive Summary and Market Analysis

The market is divided into key regions: the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The growth of this market is driven by several factors, including advancements in technology and the efforts of market players. Additionally, improvements in healthcare infrastructure, a rising incidence of chronic diseases, supportive government initiatives, and strategic actions by companies are contributing to the expansion of the embolization devices market in the region. The integration of modern technologies is also a significant factor in this growth. Countries like the UAE and Saudi Arabia are witnessing increased healthcare investments and infrastructure development, which facilitate the adoption of advanced medical technologies, leading to enhanced healthcare facilities and a more skilled workforce, thereby increasing the demand for embolization devices.

Market Segmentation Analysis

The Middle East and Africa embolization devices market can be segmented by type, application, and end user:

By Type: The market includes embolization coils, plugs, beads, glues, and other devices. In 2024, embolization coils held the largest market share, with further segmentation into central and peripheral applications.
By Application: The applications of embolization devices are categorized into neurology, peripheral vascular disease, oncology, urology, and others. Neurology was the leading application segment in 2024.
By End User: The end users of these devices include hospitals, ambulatory centers, and others, with hospitals accounting for the largest share in 2024.

Market Outlook

The prevalence of vascular diseases, such as peripheral artery disease (PAD), aneurysms, and arteriovenous malformations (AVMs), is increasing globally, particularly among older adults and those with lifestyle-related risk factors. Peripheral vascular disease encompasses both PAD and venous diseases. Annually, approximately 500,000 deaths occur worldwide due to brain aneurysms, which are most common in individuals aged 35 to 60, with a significant number developing after age 40. Ruptured brain aneurysms contribute to 3-5% of all new strokes.

Postpartum hemorrhage is a leading cause of maternal mortality, affecting around 14 million women each year and resulting in approximately 70,000 deaths globally. Furthermore, the prevalence of uterine fibroids has surged by nearly 79% over the past 30 years, from 126.41 million to 226.05 million cases. Embolization devices are effective in treating these conditions by blocking abnormal blood flow in vessels, making them a preferred option due to their minimally invasive nature. This technique is particularly useful for managing severe bleeding after childbirth and for treating fibroids, leading to symptom relief.

Country Insights

The market is further analyzed by country, with Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa being the primary regions. South Africa held the largest market share in 2024. The Saudi government's Vision 2030 initiative aims to enhance the healthcare sector by increasing private sector involvement and investing in medical infrastructure. For example, the Ministry of Health in Saudi Arabia announced plans in 2019 to build several new hospitals. Additionally, the Gulf Cooperation Council (GCC) has committed to investing US$ 66.67 billion (SR 250 billion) in healthcare infrastructure, aiming to increase private sector participation from 40% to 65% by 2030. These initiatives are expected to strengthen the healthcare system and promote the adoption of advanced medical devices, including embolization technologies.

Company Profiles

Key players in the embolization devices market include Medtronic Plc, Cook Medical Holdings LLC, Stryker Corp, Boston Scientific Corp, Terumo Corp, Johnson & Johnson, Abbott Laboratories, NeuroSafe Medical Co. Ltd, Wallaby Medical, Sirtex Medical Ltd, GEM srl, Penumbra Inc., Balt, Lepu Medical Technology Beijing Co Ltd, INVAMED, Meril Life Sciences Pvt Ltd, Merit Medical Systems Inc, and Lifetech Scientific Corp. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.

Product Code: BMIRE00032149

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Middle East & Africa Embolization Devices Market - Key Market Dynamics

4.1 Middle East & Africa Embolization Devices Market - Key Market Dynamics
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Clinical Conditions
- 4.2.2 Burgeoning Demand for Minimally Invasive Techniques
4.3 Market Restraints
- 4.3.1 Complications Arising During or After Embolization
4.4 Market Opportunities
- 4.4.1 New Product Developments and Marketing Approvals
4.5 Future Trends
- 4.5.1 Transforming Embolization Through Clinical Innovation
4.6 Impact of Drivers and Restraints:

5. Embolization Devices Market - Middle East & Africa Analysis

5.1 Middle East & Africa Embolization Devices Market Revenue (US$ Million), 2021-2031
5.2 Middle East & Africa Embolization Devices Market Forecast Analysis

6. Middle East & Africa Embolization Devices Market Analysis - by Product Type

6.1 Embolization Coils
- 6.1.1 Overview
- 6.1.2 Embolization Coils: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Plugs
- 6.2.1 Overview
- 6.2.2 Plugs: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Beads
- 6.3.1 Overview
- 6.3.2 Beads: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Glues
- 6.4.1 Overview
- 6.4.2 Glues: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Others
- 6.5.1 Overview
- 6.5.2 Others: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Middle East & Africa Embolization Devices Market Analysis - by Application

7.1 Neurology
- 7.1.1 Overview
- 7.1.2 Neurology: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Peripheral Vascular Disease
- 7.2.1 Overview
- 7.2.2 Peripheral Vascular Disease: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Urology
- 7.4.1 Overview
- 7.4.2 Urology: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Embolization Devices Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Ambulatory Centers
- 8.2.1 Overview
- 8.2.2 Ambulatory Centers: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Embolization Devices Market - Country Analysis

9.1 Middle East & Africa
- 9.1.1 Middle East & Africa Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 Middle East & Africa Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 Saudi Arabia: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.2.1 Saudi Arabia: Middle East & Africa Embolization Devices Market Share - by Product Type
    - 9.1.1.2.2 Saudi Arabia: Middle East & Africa Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.2.3 Saudi Arabia: Middle East & Africa Embolization Devices Market Share - by Application
    - 9.1.1.2.4 Saudi Arabia: Middle East & Africa Embolization Devices Market Share - by End User
  - 9.1.1.3 South Africa: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.3.1 South Africa: Middle East & Africa Embolization Devices Market Share - by Product Type
    - 9.1.1.3.2 South Africa: Middle East & Africa Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.3.3 South Africa: Middle East & Africa Embolization Devices Market Share - by Application
    - 9.1.1.3.4 South Africa: Middle East & Africa Embolization Devices Market Share - by End User
  - 9.1.1.4 United Arab Emirates: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.4.1 United Arab Emirates: Middle East & Africa Embolization Devices Market Share - by Product Type
    - 9.1.1.4.2 United Arab Emirates: Middle East & Africa Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.4.3 United Arab Emirates: Middle East & Africa Embolization Devices Market Share - by Application
    - 9.1.1.4.4 United Arab Emirates: Middle East & Africa Embolization Devices Market Share - by End User
  - 9.1.1.5 Rest of Middle East & Africa: Middle East & Africa Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Embolization Devices Market Share - by Product Type
    - 9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Embolization Devices Market Share - by Application
    - 9.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Embolization Devices Market Share - by End User

10. Competitive Landscape

10.1 Market Concentration by Key Players
10.2 Company Market Share Analysis, 2024

11. Industry Landscape

11.1 Overview
11.2 Expansion
11.3 New Product Development and Approval
11.4 Merger and Acquisition
11.5 Partnerships and Collaboration

12. Company Profiles

12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Cook Medical Holdings LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Stryker Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boston Scientific Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Terumo Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Johnson & Johnson
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 NeuroSafe Medical Co. Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Wallaby Medical
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Sirtex Medical Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 GEM srl
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Penumbra Inc.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Balt
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Lepu Medical Technology Beijing Co Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 INVAMED
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Meril Life Sciences Pvt Ltd
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Merit Medical Systems Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
12.18 Lifetech Scientific Corp
- 12.18.1 Key Facts
- 12.18.2 Business Description
- 12.18.3 Products and Services
- 12.18.4 Financial Overview
- 12.18.5 SWOT Analysis
- 12.18.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms